{"DataElement":{"publicId":"3057653","version":"1","preferredName":"Retinoic Acid Agent Administered Begin Date","preferredDefinition":"The month, day and year that retinoid was started.","longName":"2871848v1.0:2557783v2.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2871848","version":"1","preferredName":"Retinoic Acid Agent Administered","preferredDefinition":"A group of agents that includes retinol (Vitamin A) and related compounds with potential antineoplastic and/or chemopreventive activities.  A retinoic acid agent binds to and/or activates specific nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), thereby modulating transcription of genes responsible for cell differentiation and proliferation.  A retinoic acid agent may exhibit immunomodulatory and anti-inflammatory properties and may inhibit ornithine decarboxylase, resulting in a decrease in polyamine synthesis and keratinization. (NCI04)_The act of having given something (e.g., a medication or test).","longName":"2871846v1.0:2233610v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2871846","version":"1","preferredName":"Retinoic Acid Agent","preferredDefinition":"A group of agents that includes retinol (Vitamin A) and related compounds with potential antineoplastic and/or chemopreventive activities.  A retinoic acid agent binds to and/or activates specific nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), thereby modulating transcription of genes responsible for cell differentiation and proliferation.  A retinoic acid agent may exhibit immunomodulatory and anti-inflammatory properties and may inhibit ornithine decarboxylase, resulting in a decrease in polyamine synthesis and keratinization. (NCI04)","longName":"C804","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retinoic Acid Agent","conceptCode":"C804","definition":"A group of agents that includes retinol (Vitamin A) and related compounds with potential antineoplastic and/or chemopreventive activities.  A retinoic acid agent binds to and/or activates specific nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs), thereby modulating transcription of genes responsible for cell differentiation and proliferation.  A retinoic acid agent may exhibit immunomodulatory and anti-inflammatory properties and may inhibit ornithine decarboxylase, resulting in a decrease in polyamine synthesis and keratinization. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69577665-A52F-8ABA-E040-BB89AD432DAE","latestVersionIndicator":"Yes","beginDate":"2009-05-07","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-05-07","modifiedBy":"ONEDATA","dateModified":"2009-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"69577665-A53D-8ABA-E040-BB89AD432DAE","latestVersionIndicator":"Yes","beginDate":"2009-05-07","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-05-07","modifiedBy":"KUMMEROA","dateModified":"2018-08-15","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2557783","version":"2","preferredName":"Begin Date","preferredDefinition":"Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins._The particular day, month and year an event has happened or will happen.","longName":"BEG_DT","context":"NHLBI","contextVersion":"1","type":"Non-enumerated","dataType":"DATE","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"format":"YYYY-MM-DD","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008561","version":"1","preferredName":"Occurrences","preferredDefinition":"dates, times, and durations.","longName":"OCURS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B53BD1AB-090B-398B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-01-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208020","version":"1","preferredName":"Begin Date","preferredDefinition":"Have a beginning, in a temporal, spatial, or evaluative sense.:a particular day specified as the time something has, or will, happen.","longName":"C25431:C25164","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Begin","conceptCode":"C25431","definition":"Have a beginning, in a temporal, spatial, or evaluative sense; the point in space or time where something begins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3932-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A1B282-BBC9-1DAB-E040-BB89AD4319DD","latestVersionIndicator":"Yes","beginDate":"2006-12-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-04-28","modifiedBy":"COOPERM","dateModified":"2009-05-12","changeDescription":"Created new VD version associated to different CD and Display Format as part of NMDP Date VD clean up 4/2009. mcooper","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964916","version":"1","longName":"2126r1: Neuroblastoma Post-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"neu_post_retinoid_strt_dt","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedProcedure:dateRange","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the date retinoid the","type":"Preferred Question Text","description":"Specify the date retinoid therapy was started:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:3057653","type":"BRIDG Mapping Path","description":"\"PerformedProcedure.dateRange WHERE PerformedProcedure > DefinedProcedure > Product > MaterialName.nameCode = \"\"Retinoic Acid Agent\"\"   {Post HSCT} is determined by: PerformedProcedure > DefinedProcedure > DefinedCompositeRelationship [1] > DefinedActivity > DefinedCompositeRelationship [2] > DefinedProcedure.nameCode = \"\"Administer Hematopoietic Stem Cell Product {transplantation}\"\" AND DefinedCompositeRelationship.sequenceNumber [1] IS GREATER THAN DefinedCompositeRelationship.sequenceNumber [2]\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"840CE794-02AC-AE1D-E040-BB89AD433CB1","latestVersionIndicator":"Yes","beginDate":"2010-04-12","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-04-12","modifiedBy":"KUMMEROA","dateModified":"2021-08-17","changeDescription":". System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}